The role of adoptive immunotherapy in the prevention and treatment of lymphoproliferative disease following transplantation

British Journal of Haematology

Volumn 106, Issue 2, 1999, Pages 309-316

  Haque, Tanzina ^a   Crawford, Dorothy H ^a  

^a NONE

Author keywords

Cytotoxic T cells; Epstein Barr virus; Immunotherapy; Lymphoproliferative disease; Transplantation

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; MONOCLONAL ANTIBODY; OKT 3; STEROID; TACROLIMUS;

ADOPTIVE IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW;

FORECASTING; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOTHERAPY; LYMPHOPROLIFERATIVE DISORDERS; TRANSPLANTATION; TUMOR VIRUS INFECTIONS;

EID: 0032823955     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01503.x     Document Type: Review

References (68)

1. Alfrey, E.J., Friedman, A.L., Grossman, R.A., Perloff, L.J., Naji, A., Barker, C.F. & Montone, K.T. (1992) A recent decrease in the time to development of monomorphous and polymorphous post-transplant lymphoproliferative disorder. Transplantation, 54, 250-253.
2. Armitage, J.M., Kormos, R.L., Stuart, S., Fricker, F.J., Griffith, B.P., Nalesnik, M., Hardesty, R.L. & Dummer, J.S. (1991) Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporin-based immunosuppression. Journal of Heart and Lung Transplantation, 10, 877-887.
3. Benkerrou, M., Jais, J. P., Leblond, V., Durandy, A., Sutton, L., Borigoni, P., Garnier, J. L., Le Bidois, J., Le Deist, F., Blanche, S. & Fischer, A. (1998) Anti-B cell monoclonal antibody treatment of severe post-transplant B-lymphoproliferative disorder: prognostic factors and long-term outcome. Blood, 92, 3137-3147.
4. Bogedain, C., Wolf, H., Modrow, S., Stuber, G. & Jilg, W. (1995) Specific cytotoxic T lymphocytes recognise the immediate early transactivator Zta of Epstein-Barr virus. Journal of Virology, 69, 4872-4879.
5. Bourgault, I., Gomez, A., Gomard, E. & Levy, J.P. (1991) Limiting dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. Clinical and Experimental Immunology 84, 501-507.
6. Burman, K. & Crawford, D.H. (1991) Effect of FK506 on Epstein-Barr virus specific cytotoxic T cells. Lancet, 337, 297-298.
7. + T cells in acute mononucleosis. Nature Medicine, 2, 906-911.
8. Cen, H., Breinig, M.C., Atchison, K.W., Ho, M. & McKnight, J.L.C. (1991) Epstein-Barr virus transmission via the donor organ in solid organ transplantation: polymerase chain, reaction and restriction fragment length polymorphism analysis of 1R2, 1R3 and 1R4. Journal of Virology, 65, 976-980.
9. Cen, H., William, P.A., McWillaiam, H.P., Breinig, M.C., Ho, M. & McKnight, J.L.C. (1993) Evidence of restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with post-transplant lymphoproliferative disorders. Blood, 81, 1393-1403.
10. Cleary, M.L. & Sklar, J. (1984) Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas. Lancet, ii, 489-493.
11. Crawford, D.H., Epstein, M.A., Bornkamn, G.W., Achong, B.G., Finerty, S. & Thompson, J.L. (1980) Epstein-Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in a patient with renal allograft. Lancet, i, 1355-1356.
12. Dockrell, D.H., Strickler, J.G. & Paya, C.V. (1998) Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients. Clinical Infectious Diseases, 26, 180-182.
13. Epstein, M.A. & Crawford, D.H. (1998) Gammaherpesviruses: Epstein-Barr virus. Topley and Wilson's Microbiology and Microbial Infections, 9th edn (ed. by L. Collier, A. Balows and M. Sussman), Vol. 1, pp. 351-566. Arnold, London.
14. Faro, A., Kurland, G., Michaels, M.G., Dickmam, P.S., Greally, P.G., Spichty, K.J., Noyes, B.B., Boas, S.R., Pricker, F.J., Armitage, J.M. & Zeevi, A. (1996) Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder. American Journal of Respiratory Critical Care Medicine, 153, 1442-1447.
15. Fischer, A., Blanche, S. & Bidois, J. (1991) Anti B cell monoclonal antibodies in the treatment of severe B cell lymphoproliferative syndrome following bone marrow and organ transplantation. New England Journal of Medicine, 324, 1451-1457.
16. Frizzera, G., Hanto, D.W., Gajl-Peczalska, K.J., Rosai, J., McKenna, R.W, Sibley, R.K., Holahan, K.P. & Lindquist, L.L. (1981) Polymorphic diffuse B cell hyperplasia and lymphomas in renal transplant recipients. Cancer Research, 41, 4262-4279.
17. Hanto, D.W., Frizzera, G., Gajl-Peczalska, K.J., Sakamoto, K., Purtilo, D.T., Balfour, H.H., Simmons, R.L. & Najarian, J.S. (1982) Acydovir therapy and transition from polyclonal to monoclonal B cell proliferation. New England Journal of Medicine, 306, 913-918.
18. Haque, T., Amlot, P., Helling, N., Thomas, J.A., Sweny, P., Rolles, K., Burroughs, A., Prentice, H.G. & Crawford, D.H. (1998) Restoration of EBV-specific T cell immunity in solid organ transplant recipients. Journal of Immunology, 160, 6204-6209.
19. Haque, T., Thomas, J.A., Falk, K., Parratt, R., Hunt, B., Yacoub, M. & Crawford, D.H. (1996) Transmission of donor Epstein-Barr virus in transplanted organ causes lymphoproliferative diseases in recipient. Journal of General Virology, 77, 1169-1172.
20. Haque, T., Thomas, J.A., Parratt, R., Hunt, B., Yacoub, M. & Crawford, D.H. (1997) A prospective study in heart and lung transplant recipients correlating persistent Epstein-Barr virus infection with clinical events. Transplantation, 64, 1028-1034.
21. Henle, G. & Henle, W. (1979) The virus as the etiologic agent of infectious mononucleosis. The Epstein-Barr Virus (ed. by M. A. Epstein and B. G. Achong). pp. 297-320. Springer, Berlin.
22. Henle, G., Henle, W. & Diehl, W. (1968) Relation of Burkitt's tumor associated herpes-type virus to infectious mononucleosis. Proceedings of the National Academy of Sciences of the United States of America, 59, 94-101.
23. Ho, M., Miller, G., Wayne, A., Breinig, M., Dummer, J., Andiman, W., Starzl, T., Eastman, R., Griffith, B.P., Hardesty, R., Bahnson, H., Hakala, T. & Rosenthal, J. (1985) Epstein-Barr virus infection and DNA hybridisation studies in post-transplant lymphomas and lymphoproliferative lesions: the role of primary infection. Journal of Infectious Diseases, 152, 876-886.
24. Ho, M,. Jaffe, R., Miller, G., Breinig, M.K., Dummer, J.S., Makowka, L., Atchison, R.W., Karrer, F., Nalesnik, M.A. & Starzl, T.E. (1988) The frequency of Epstein-Barr virus infection and associated lymphoproliferative disease after transplantation and its manifestations in cehildren.Transplantation, 45, 719-727.
25. Kieff, E. (1996) Epstein-Barr virus and its replication. Field's Virology, 3rd edn (ed. by B. N. Fields, D. M. Knipe and P. M. Howley). pp. 2343-2396. Lippincott-Raven Publishers, Philadelphia, Pa.
26. Kino, T., Hatanaka, H. & Miyata, S. (1987) FK-506, a novel immunosuppressant isolated from Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. Journal of Antibiotics, 40, 1256-1265.
27. Knowles, D. M., Cesarman, H., Chadburn, A., Frizzera, G., Chen, J., Rose, E. A. & Michler, R. E. (1995) Correlative morphologic, and molecular genetic analysis demonstrates three distinct categories of post-transplantation lymphoproliferative disorders. Blood, 85, 552-565.
28. Leblond, V., Davi, E., Charlotte, E., Dorent, R., Bitker, M., Sutton, L., Gandjbakch, I., Binet, J. & Raphael, M. (1998) Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? Journal of Clinical Oncology, 2052-2059.
29. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P.M., Klein, G., Kurilla, M.G. & Masucci, M.G. (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen I. Nature, 375, 685-688.
30. Mathur, A., Kamat, D.M., Filipovich, A.H., Steinbuch, M. & Shapiro, K.S. (1994) Immunoregulatory abnormalities in patients with Epstein-Barr virus-associated B cell lymphoproliferative disorders. Transplantation, 57, 1042-1045.
31. Miyashita, E.M., Yang, B., Lam, K.M.C., Crawford, D.H. & Thorley-Lawson, D.A. (1995) A novel form of Epstein-Barr virus latency in normal B cells. Cell, 80, 593-601.
32. Moss, D.J., Wallace, L.H., Rickinson, A.B. & Epstein, M.A. (1981) Cytotoxic T-cell recognition of Epstein-Barr virus infected B-cells. I. Specificity and HLA-restriction of effector cells reactivated in vitro. European Journal of Immunology, 11, 686-693.
33. Moss, D.J., Suhrbier, A. & Elliott, S.L. (1998) Candidate vaccines for Epstein-Barr virus. British Medical Journal, 317, 423-424.
34. Murray, R.J., Kurilla, S.R., Moss. D.J., Griffith, H.M., Brooks, J.M., Mackett, M., Arrand, J.R., Rowe, M., Burrows, S.R., Moss, D.J. & Kieff, E. (1990) Human cytotoxic T cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses. Proceedings of the National Academy of Sciences of the United States of America, 87, 2906-2910.
35. Nalesnik, M.A. (1990) Involvement of the gastrointestinal tract by Epstein-Barr virus-associated posttransplant lymphoproliferalive disorders. American Journal of Surgical Pathology, 14, 92-100.
36. Nalesnik, M.A., Rao, A.S., Furukawa, H., Pham, S., Zeevi, A., Fung, J.J., Klein, G., Gritsch, H.A., Elder, E., Whiteside, T.L. & Starzl, T.E. (1997) Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. Transplantation, 63, 1200-1205.
37. Nalesnik, M.A., Zeevi, A., Randhawa, P.S., Faro, A., Spichty, K.J., Demetris, A.J., Fung, J.J., Whiteside, T.L. & Starzl, T.E. (1999) Cytokine mRNA profile in Epstein-Barr virus-associated posttransplant lymphoproliferative disorders. Clinical Transplantation, 13, 39-44.
38. Niedobitek, G., Mutimer, D.J., Williams, A., Whitehead, L., Wilson, P., Rooney, N., Voung, L.S. & Hubscher, S.G. (1997) Epstein-Barr virus infection and malignant lymphomas in liver transplant recipients. International Journal of Cancer 73, 514-420.
39. Opelz, G. & Henderson, R. (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet, 342, 1514-1516.
40. Papadopoulos, E.B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M.H., Castro-Malaspina, H., Childs, B.H., Gillio, A.P., Small, T.H., Young, J.W., Kernan, N.A. & O'Reilly, R.J. (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New England lournal of Medicine, 330, 1185-1191.
41. Penn, I. (1994) The problem of cancer in organ transplant recipients: an overview. Transplantation Science, 4, 23-32.
42. Penn, I. (1998) The role of immunosuppression in lymphoma formation. Springer Seminars in Immunopathology. 20, 343-355.
43. Penn, I. & Porat, G. (1995) Central nervous system lymphomas in organ allograft recipients. Transplantation, 59, 240-244.
44. Ferera, S.M., Thomas, J.A., Burke, M. & Crawford. D.H. (1998) Analysis of the T cell micro-environment in Epstein-Barr virus-related post-transplantation B lymphoproliferative disease. Journal of Pathology, 184, 177-184.
45. Pope. J.H., Horne, M.K. & Scott, W. (1968) Transformation of human foetal leukocytes in vitro by infiltrates of a human leukaemia cell line containing herpes-like virus. International Journal of Cancer, 3, 857-866.
46. Renard, T.H., Andrews, W.S. & Foster, M.E. (1991) Relationship between OKT3 administration, EBV seroconversion and the lymphoproliferative syndrome in paediatric liver transplant, recipients. Transplantation Proceedings, 23, 1473-1476.
47. Riddell, S.R., Watanabe. K.S. & Goodrich, J.M. (1992) Restoration of viral immunity in immunodeficient humans by adoptive transfer of T cell clones. Science, 257, 238-241.
48. Rocchi, G., Felici, A.D., Ragona, C. & Heinz, A. (1977) Quantitative evaluation of Epstein-Barr virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. New England Journal of Medicine. 296, 132-134.
49. Rooney, C.M., Heslop, H.E. & Brenner, M.E. (1998a) EBV-specific CTL: a model for immune therapy. Vox Sanguinis, 74, 497-498.
50. Rooney, C.M., Smith, C.A., Ng, C.Y.C., Loftin, S., Li. C., Krance, R.A. & Brenner, M.K. (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr virus-related lymphoproliferation. Lancet, 345, 9-13.
51. Rooney, C.M., Smith, C.A., Ng, C.Y.C., Loftin, S.K., Sixbey, J.W., Gan, Y., Srivastava, A., Bowman, L.C., Krance, R.A., Brenner, M.K. & Heslop, H.E. (1998b) Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood, 92, 1549-1555.
52. Savoie, A., Perpete, C., Carpentier, L., Joncas, J. & Alfieri, C. (1994) Direct, correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease. Blood, 9, 2715-2722.
53. Shapiro, R.S., Chauvenet, A., McGuire, W., Pearson, A., Craft, A.W., McGlave, P. & Filipovich, A.H. (1988a) Treatment of B cell lymphoproliferative disorders with interferon alpha and intravenous gamma globulin. New England Journal of Medicine, 318, 1334.
54. Shapiro, R.S., McClain, K., Frizzera, G., Gajl-Peczalska, K.J., Kersey, J.H., Blazar, B.R., Arthur, D.C., Patton, D.F., Greenberg, J.S., Burke, B., Ramsay, N.K.C., McGlave, P. & Filipovich, A.H. (1988b) Epstein-Barr virus associated B cell lymphoproliferalive disorders following bone rnarrow transplantation. Blood, 71, 1234-1243.
55. Shearer, W.T., Ritz, J., Finegold, M.J., Guerra, I.C., Rosenblatt, H.M., Lewis, D.E., Pollack, M.S., Taber, L.H., Sumaya, C.V., Grumet, F.C., Cleary, M.L., Warnke, R. & Sklar, J. (1985) Epstein-Barr virus-associated B cell proliferation of diverse clonal origins after bone marrow transplantation in a 12-year-old patient with severe combined immunodeficiency. New England Journal of Medicine, 312, 1151-1159.
56. Sixbey, J.W., Nedrud, J.G., Raab-traub, N., Hanes, R.A. & Pagano, J.S. (1984) Epstein-Barr virus replication in oropharyngeal epithelial tells. New England Journal of Medicine, 310, 1225-1230.
57. Starzl, T.F., Proter, D.A. & Iwatusuki, S. (1984) Reversibility of lymphomas or lymphoproliferative lesions developing under cyclosporin-steroid therapy, Lancet, i, 583-587.
58. Stevens, N.M., Annels, N.E., Kumar, A., Leese, A.M., Kurilla, M.G. & Rickinson, A.B. (1997) Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. Journal of Experimental Medicine, 185, 1605-1617.
59. Swinnen, L.J., Mullen, G.M., Carr, T.J., Costanzo, M.R. & Fisher, R.I. (1995) Aggressive treatment for post-cardiac transplant lymphoproliferation. Blood, 86, 3333-3340.
60. Thomas, J.A., Hotchin, N.A., Allday, M.J., Amlot, P., Rose, M., Yacoub, M. & Crawford, D.H. (1990) Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation, 49, 292-301.
61. Thomson, S.A., Sherritt, M.A., Medveczky, J., Elliolt, S.L., Moss, D.J., Fernando, G.J., Brown, L.E. & Suhrbier, A. (1998) Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. Journal of Immunology, 160, 1717-1723.
62. Tierney, R.J., Steven, N., Young. L.S. & Rickinson, A.B. (1994) Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. Journal of Virology, 68, 7174-7385.
63. Tosato, G., Jones, K., Breinig, M.K., McWilliams, H.P. & McKnight, J.L. (1993) Interleukin-6 production in posttransplant lymphoproliferative disease. Journal of Clinical Investigation, 91, 2806-2814.
64. Tsoukas, C.D., Carson, D.A., Fong, S. & Vaughan, J.H. (1982) Molecular interactions in human T cell-mediated cytotoxicity to EBV. II. Monoclonal antibody OKT3 inhibits a post-killer recognition/adhesion step. Journal of Immunology 129, 1421-1425.
65. Wallace, C.E., Rickinson, A.B., Rowe, M. & Epstein, M.A. (1982) Epstein-Barr virus-specific cytotoxic T-cell clones restricted through a single HLA antigen. Nature, 297, 413-415.
66. Weiss, L.M. & Movahed, L.A. (1989) In situ demonstration of Epstein-Barr viral genomes in viral-associated B lymphoproliferation. American Journal of Pathology, 134, 651-659.
67. Weissmann, D.J., Ferry, J.A., Harris, N.L., Louise, D.N., Delmonico, F. & Spiro, I. (1995) Posttransplantation lymphoproliferative disorders in solid organ recipients are predominantly aggressive tumors of host origin. American Journal of Clinical Pathology, 103, 748-755.
68. Young, L., Alfieri, C. & Hennesy, K. (1989) Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. New England Journal of Medicine, 321, 1080-1085.